Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma

Clara Backes; Henning Bier; Andreas Knopf

doi:10.18632/oncotarget.21035

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma

Clara Backes, Henning Bier and Andreas Knopf _

PDF | HTML | How to cite

Oncotarget. 2017; 8:84320-84328. https://doi.org/10.18632/oncotarget.21035

Metrics: PDF 1356 views | HTML 2104 views | ?

Abstract

Clara Backes1, Henning Bier1 and Andreas Knopf1

1Otorhinolaryngology/Head and Neck Surgery, Klinikum rechts der Isar, Technische Universität München, 81675 München, Germany

Correspondence to:

Andreas Knopf, email: [email protected]

Keywords: R0, tumor free margin, head and neck, adjuvant therapy, surgery

Received: June 10, 2017 Accepted: August 05, 2017 Published: September 16, 2017

ABSTRACT

Objectives: The resection status is one of the most important prognostic factors for patients with head and neck squamous cell carcinoma (HNSCC) concerning overall survival (OS) and recurrence free interval (RFI). To assess whether therapy concepts changed depending on different resection margins and extracapsular extension, OS and RFI data were set into clinical context.

Methods: All HNSCC patients who underwent head and neck surgery with/without adjuvant therapy (n=534) were selected over a ten-year period (2001-2011). Clinical parameters and survival data were collected retrospectively and histopathological analysis of tumor free margins and extracapsular extension were done.

Results: Patients with microscopic in-sano resection showed mean OS/RFI of 95/96 months. OS/RFI decreased in microscopic non-in-sano and macroscopic non-in-sano (56/58 and 35/39 months) as well as in unclear resection margins (63/60 months). Patients with extracapsular extension, microscopic non-in-sano resection as well as patients with in-sano resection after follow up resection demonstrated therapy escalation by adjuvant (chemo-) radiation.

Conclusions: Insufficient surgical margins and extracapsular extension are main risks for a reduced overall and recurrence free survival. Although there is no measure to prevent positive extracapsular extension, clear margins at first pass protect patients from adjuvant therapy escalation.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21035

Publication Alerts

Research Papers:

Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma

Abstract